Iovance downgraded at Goldman Sachs citing concerns on lead asset
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
11,460$
2,41%
Echtzeit-Aktienkurs Iovance Biotherapeutics Inc.
Bid:
Ask:
Nachrichten zur Iovance Biotherapeutics Inc. Aktie
Why did Iovance Biotherapeutics stock climb today? $65M insider buy
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Iovance Biotherapeutics Stock Up 20% After Director Buys 10M Shares
Iovance Biotherapeutics Stock Up 20% After Director Buys 10M Shares...…
Pre-market Movers: Iovance Biotherapeutics, Dada Nexus, Shuttle Pharmaceuticals, Bilibili, Bioventus
BRASILIA (dpa-AFX) - The following are some of the stocks making big moves in Mondays pre-market trading (as of 07.35…
Pre-market Movers: IOVA, DADA, SHPH, BILI, BVS.
BRASILIA (dpa-AFX) - The following are some of the stocks making big moves in Mondays pre-market trading (as of 07.35…
Iovance adds 21% on $65M insider purchase
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
$65 Million Bet On Iovance Biotherapeutics? Check Out These 3 Stocks Insiders Are Buying
Although US stocks closed mixed on Friday, there were a few notable insider trades.
read more...…
Insiderhandel: Aufsichtsrat kauft Aktien von Iovance Biotherapeutics im Wert von 65.000.000$
Rothbaum, Wayne P. - Aufsichtsrat - Tag der Transaktion: 2022-12-02...…
Insiderhandel: Interim CEO & General Counsel kauft Aktien von Iovance Biotherapeutics im Wert von 5.980$
Vogt, Frederick G. - Vorstand - Tag der Transaktion: 2022-11-28...…
Insiderhandel: Aufsichtsrat kauft Aktien von Iovance Biotherapeutics im Wert von 61.800$
Mcpeak, Merrill A. - Aufsichtsrat - Tag der Transaktion: 2022-11-28...…
Insiderhandel: Aufsichtsrat kauft Aktien von Iovance Biotherapeutics im Wert von 61.000$
Dukes, Iain D. - Aufsichtsrat - Tag der Transaktion: 2022-11-23...…
Iovance (IOVA) Extends Timeline for Rolling BLA of Melanoma Drug
Post FDAs feedback on lifileucel, Iovance (IOVA) extends its timeline to complete the rolling BLA submission for lifileucel in melanoma.…
Form 8-K IOVANCE BIOTHERAPEUTICS, For: Nov 18
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Why Iovance Biotherapeutics Is Crashing Today
The FDA is asking the drug development outfit for more information regarding its tumor-infiltrating lymphocyte therapy....…
Iovance falls 12% as rolling review filing extended after FDA seeks more data
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Iovance Shares Fall Premarket on Lifileucel FDA Filing Delay >IOVA
Iovance Shares Fall Premarket on Lifileucel FDA Filing Delay >IOVA...…
Iovance Biotherapeutics Provides Update on Biologics License Application Submission for Lifileucel in Advanced Melanoma
BLA Submission Ongoing with U.S. Food and Drug Administration BLA Submission Ongoing with U.S. Food and Drug Administration...…
Iovance Biotherapeutics Announces Updated Clinical Data for Lifileucel in Advanced Melanoma at Society for Immunotherapy of Cancer (SITC) Annual Meeting
31% Objective Response Rate (ORR) and Median Duration of Response (mDOR) Not Reached at 36.5 Months Median Study Follow Up…
Form 10-Q IOVANCE BIOTHERAPEUTICS, For: Sep 30
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Iovance Biotherapeutics to Host Third Quarter Financial Results Conference Call and Webcast on Thursday, November 3, 2022
SAN CARLOS, Calif., Oct. 24, 2022 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company…
Iovance (IOVA) Doses First Patient in TIL Cancer Therapy Study
Iovance (IOVA) doses the first patient in phase I/II study evaluating its TIL therapy candidate, IOV-4001, in adults with metastatic…
Iovance Biotherapeutics Announces First Patient Dosed with PD-1 Inactivated Tumor Infiltrating Lymphocyte (TIL) Therapy
First Genetically Modified (TALEN®-edited) Iovance TIL Therapy with Inactivated PD-1 Expression...…
Iovance (IOVA) Focuses on Seeking Nod for Melanoma Therapy
Iovance (IOVA) is progressing with its pipeline development. Management, after many delays, initiated a rolling BLA filing with the FDA…